Navigation Links
Chindex-Fosun Pharma Joint Venture, Chindex Medical, To Participate in Acquisition of Alma Lasers; Fosun Pharma Increases Investment in Chindex Medical
Date:4/29/2013

BETHESDA, Md., April 29, 2013 /PRNewswire/ -- Chindex International, Inc. (NASDAQ: CHDX, "Chindex"), an American healthcare company providing healthcare services in China, today announced that Chindex Medical Limited ("CML"), its joint venture with Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma"), has agreed to acquire approximately 36.17% of Alma Lasers, Inc. ("Alma") for approximately $53.5 million as part of a purchase by a group of buyers for substantially all of Alma. The buying group, which consists of CML, another subsidiary of Fosun Pharma and the Pramerica-Fosun China Opportunity Fund, would acquire substantially all of Alma indirectly through a jointly-owned entity. The total acquisition price by all buyers for Alma would be approximately $240 million, including indebtedness incurred at the Alma level, without recourse to CML.

In order to help fund the acquisition by CML of its interest in Alma, Fosun Pharma has agreed to invest approximately $41 million in cash in CML for additional equity in CML. Following such investment, CML, which currently is owned 51% by Fosun Pharma and 49% by Chindex, would be owned 70% by Fosun Pharma and 30% by Chindex. In connection with this investment Chindex has waived its participation in such investment and agreed to increase FosunPharma's board seats at CML from four of seven to five of eight.

Alma is a leading global medical energy-based (including lights, laser, radio frequency and ultrasonic) device manufacturer, with a comprehensive product offering and international sales network. Alma has developed leading R & D capabilities globally in the medical and aesthetic equipment manufacturing field and established a global brand in the market segment. Alma has an established record of sustained performance results. In 2012, Alma recorded nearly $100 million total revenue.

Roberta Lipson '/>"/>

SOURCE Chindex International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharmaceutical Market: Finland, Ireland, Denmark, Belgium, Cuba, Austria & Norway
2. Oramed Pharmaceuticals to Present Results of its Key Clinical Studies of Oral Insulin in Type 1 Diabetes Patients at the GTC Diabetes Summit, Boston, MA; April 29-30, 2013
3. Comprehensive Care Corporation Names Colonel Ramon Martinez President of CompCare Pharmacy Solutions, Inc.
4. Auxilium Pharmaceuticals Completes Acquisition Of Actient Holdings LLC To Create A Leading Urology Franchise With A Diversified Product Portfolio And Strong Growth Profile
5. Absorption Pharmaceuticals to Receive Patent for Premature Ejaculation Topical Medication
6. Care Corporation Names Colonel Ramon Martinez President of CompCare Pharmacy Solutions, Inc.
7. Simcere Pharmaceutical Group Filed 2012 Annual Report on Form 20-F
8. Novartis Pharmaceuticals Corporation disputes allegations in two US Government lawsuits and looks forward to a fair discussion of the facts
9. National Association of Specialty Pharmacy (NASP) Appoints Thomas Blissenbach, RPh, MS as a Member of The Board of Directors
10. Pharmacy Benefits Academy Heads West, May 13-14 in Portland
11. Cannabis Science announces preclinical development program for CS-TATI-I, commencing EU operations in the Netherlands and sourcing proprietary material for pharmacokinetic characterization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... (NASDAQ: STAA ), a leading developer, manufacturer and marketer ... reported financial results for the second quarter ended July 3, ... Sales of $18.7 Million Down 7% from the Prior Year ... the Weakening Euro and Yen , ICL Units Increased ... Sales Down 1% Including Korea - Up 16% Excluding Korea ...
(Date:7/29/2015)... July 29, 2015 Neurocrine Biosciences, Inc. (NASDAQ: NBIX ... 30, 2015. For the second quarter of 2015, the Company reported ... compared to a net loss of $13.4 million, or $0.18 loss ... months ended June 30, 2015, the Company reported a net loss ... net loss of $25.2 million, or $0.35 loss per share, for ...
(Date:7/29/2015)... , July 29, 2015 Immune Pharmaceuticals Inc. ... secured financings of up to $21.5 million through two ... Inc. (NYSE: HTGC ) ("Hercules"), for a term loan ... mutual fund Discover Growth Fund ("Discover"), for the sale ... Preferred Stock ("Preferred Stock") for up to $12 million ...
Breaking Medicine Technology:STAAR Surgical Reports Second Quarter 2015 Results 2STAAR Surgical Reports Second Quarter 2015 Results 3STAAR Surgical Reports Second Quarter 2015 Results 4STAAR Surgical Reports Second Quarter 2015 Results 5STAAR Surgical Reports Second Quarter 2015 Results 6STAAR Surgical Reports Second Quarter 2015 Results 7STAAR Surgical Reports Second Quarter 2015 Results 8STAAR Surgical Reports Second Quarter 2015 Results 9STAAR Surgical Reports Second Quarter 2015 Results 10STAAR Surgical Reports Second Quarter 2015 Results 11STAAR Surgical Reports Second Quarter 2015 Results 12STAAR Surgical Reports Second Quarter 2015 Results 13STAAR Surgical Reports Second Quarter 2015 Results 14STAAR Surgical Reports Second Quarter 2015 Results 15STAAR Surgical Reports Second Quarter 2015 Results 16STAAR Surgical Reports Second Quarter 2015 Results 17STAAR Surgical Reports Second Quarter 2015 Results 18STAAR Surgical Reports Second Quarter 2015 Results 19STAAR Surgical Reports Second Quarter 2015 Results 20STAAR Surgical Reports Second Quarter 2015 Results 21STAAR Surgical Reports Second Quarter 2015 Results 22STAAR Surgical Reports Second Quarter 2015 Results 23STAAR Surgical Reports Second Quarter 2015 Results 24Neurocrine Biosciences Reports Second Quarter 2015 Results 2Neurocrine Biosciences Reports Second Quarter 2015 Results 3Neurocrine Biosciences Reports Second Quarter 2015 Results 4Neurocrine Biosciences Reports Second Quarter 2015 Results 5Neurocrine Biosciences Reports Second Quarter 2015 Results 6Neurocrine Biosciences Reports Second Quarter 2015 Results 7Neurocrine Biosciences Reports Second Quarter 2015 Results 8Neurocrine Biosciences Reports Second Quarter 2015 Results 9Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 2Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 3Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 4Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 5
(Date:7/29/2015)... ... July 29, 2015 , ... ... that Columbia University Medical Center, located in New York, NY, selected the ReadyCam ... easy for physicians and scientists to immediately access worldwide TV and cable news ...
(Date:7/29/2015)... NJ (PRWEB) , ... July 29, 2015 , ... Andrzej ... Dr. Andrzej Klos, a board-certified pediatrician for nearly 38 years, is motivated each and ... dedication and commitment to his profession shine alongside his many awards and accolades, which ...
(Date:7/29/2015)... ... ... " Core Organizer ” was featured on NewsWatch as part of its monthly AppWatch, ... iOS, Android, and Windows. Joe Toohey, the host of AppWatch and technology expert, conducted ... organized. , Wouldn’t it be great if everyone could be a little more organized? ...
(Date:7/29/2015)... ... July 29, 2015 , ... The report “Atherosclerosis - Pipeline ... is a slow, progressive disease that may start in childhood. The report strengthens ... products. Complete report on Atherosclerosis Pipeline with 78 market data tables and 15 ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... with its Topricin® Pain Relief and Healing Cream designated as the nonprofit’s natural ... that is actively addressing Line of Duty Deaths (LODD) and the high rate ...
Breaking Medicine News(10 mins):Health News:Columbia University Medical Center Installs a VideoLink ReadyCam® Video Studio on Campus; Medical Experts Able to Appear on Live TV at a Moment's Notice 2Health News:Columbia University Medical Center Installs a VideoLink ReadyCam® Video Studio on Campus; Medical Experts Able to Appear on Live TV at a Moment's Notice 3Health News:NJ Top Docs Presents, Dr. Andrzej Klos of Carepoint Health Pediatrics! 2Health News:NJ Top Docs Presents, Dr. Andrzej Klos of Carepoint Health Pediatrics! 3Health News:Get More Organized with the Core Organizer App 2Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 2Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 3Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 4Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 5Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 6
... that people choosing to live near to outdoor recreation amenities ... to an increase in all that healthy outdoor activity right ... looking at the relationship between reasons for choosing a neighbourhood ... not the case. In fact researchers found that ...
... 2010: Workplace wellness programmes play a vital role in ... Day(1) theme is to encourage employers and employees to ... The European Society of Cardiology(2) is keen to support ... two major initiatives at the next EuroPRevent Meeting(3) in ...
... month that MALAT1, a long non-coding RNA that is implicated ... in the earliest stage of protein production. Their study appears ... percent of the human genome codes for proteins, and scientists ... of the "non-coding" genome. Among the least studied non-coding genes ...
... By Steven Reinberg HealthDay Reporter , THURSDAY, Sept. ... become narrowed, restricting blood flow to the brain, having a ... over a 10-year period, British researchers report. The carotid ... supplies blood carrying oxygen to the head, so a procedure ...
... victims of motorcycle crashes were 1.5 times more likely ... even though many more of the African-American victims were ... a new study by Johns Hopkins researchers. Results ... the August issue of the American Journal of ...
... UCLA,s Jonsson Comprehensive Cancer Center have discovered a new ... a pathway that, when defective, helps promote the formation ... and leukemia. , The new pathway, part of a ... some that have are known to cause cancer because, ...
Cached Medicine News:Health News:Moving closer to outdoor recreation not a recipe for being more physically active 2Health News:ESC announces new initiatives for workplace heart health programs 2Health News:ESC announces new initiatives for workplace heart health programs 3Health News:Cancer-associated long noncoding RNA regulates pre-mRNA splicing 2Health News:Cancer-associated long noncoding RNA regulates pre-mRNA splicing 3Health News:Surgery to Widen Neck Arteries Cuts 10-Year Stroke Risk: Study 2Health News:Surgery to Widen Neck Arteries Cuts 10-Year Stroke Risk: Study 3Health News:Black motorcyclists -- even in helmets -- more likely to die in crashes 2Health News:UCLA cancer researchers discover new signaling pathway that controls cell development and cancer 2Health News:UCLA cancer researchers discover new signaling pathway that controls cell development and cancer 3
... ,Allied Healthcares Timeter® PCS 414 portable air ... compressors that you may wonder if its running. ... features a durable, mar-resistant steel case thats easy ... only 26.5 pounds. The PCS 414 has been ...
... most compact, portable DC powered compressor ... provides the freedom to take nebulizer ... is powered by the included AC ... and Battery Kit. The integral reusable ...
The 45 PSI SuperSportNeb provides superior performance that translates to shorter treatment times. Like the SportNeb, it is constructed with die-cast aluminum compressor components for consistent rel...
... The new DeVilbiss PulmoAide Compact Compressor provides ... small size allows for therapy at home or ... a 5-year warranty, and the same reliable operation ... ,The PulmoAide Compact Compressor is the perfect ...
Medicine Products: